Top Markets
Coin of the day
Imaging Biometrics Ltd. Imaging Biometrics Ltd.

Imaging Biometrics Ltd.

IBAI
株式のランク #41258
Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier,... Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier, Jersey, specializes in medical imaging diagnostics and clinical patient care. The company extends its services across the United Kingdom, Switzerland, the European Union, and the United States. Its operations are structured into three main segments: a Holding Company, Medical Software, and Oral Gallium Maltolate (GaM). The Medical Software division develops a comprehensive suite of ready-to-use software applications for the healthcare sector. This portfolio includes IB Clinic, which serves as the foundational platform for all IB software; IB Neuro, a specialized platform for MR DSC perfusion processing; and IB Delta Suite, designed to generate Delta T1 maps from routine MR examinations. Further offerings comprise IB DCE and IB Diffusion, both providing in-depth insights into blood flow and water diffusion throughout the body. For non-invasive assessments, the company provides StoneChecker and Liver Surface Nodularity, which are computed tomography (CT) processing tools that assist clinicians in evaluating kidney stones and liver health. Additional software includes IB ASL, used to measure cerebral blood flow for diagnosing conditions like stroke and dementia, and IB Zero G, an innovative technology that eliminates the need for gadolinium contrast agents in standard imaging. The suite also features IB Nimble, facilitating virtual collaboration among healthcare professionals. Beyond software, the company's Oral Gallium Maltolate (GaM) segment is actively pursuing the development of IB003, a gallium maltolate drug candidate currently in Phase 1 clinical trials for treating glioblastoma. Imaging Biometrics Ltd. also offers consulting services. The entity, which was previously known as IQ-AI Limited, is slated to adopt the name Imaging Biometrics Ltd. in May 2025.
株価
$0.01197417
時価総額
$29.54K
変化(1日)
13.55%
変化(1年)
22.84%
JE
取引 Imaging Biometrics Ltd. (IBAI)

カテゴリー

Imaging Biometrics Ltd.(IBAI)のP/S比率
September 2026 時点のP/S比率 TTM: 2.71
Imaging Biometrics Ltd. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 2.71 です。2023 年末時点でのP/S比率は 14.17 でした。
Imaging Biometrics Ltd. の P/S 比率の履歴(2000 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
2026 (TTM) 2.71 -33.33%
2024 4.07 -71.29%
2023 14.17 127.82%
2022 6.22 -68.74%
2021 19.89 -66.52%
2020 59.42 214.33%
2019 18.90 54.90%
2018 12.20 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 -100.00%
2014 5.92 -52.35%
2013 12.42 1.87%
2012 12.19 2,019.35%
2011 0.58 -76.20%
2010 2.42 326.54%
2009 0.57 158.39%
2008 0.22 -72.35%
2007 0.79 -54.70%
2006 1.75 37.25%
2005 1.27 -18.72%
2004 1.57 47.19%
2003 1.07 3.53%
2002 1.03 7.49%
2001 0.96 30.09%
2000 0.74 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差
1.43 -47.17%
US
7.61 180.50%
US
66.12 2,336.73%
AU
0.82 -69.65%
US
14.43 431.74%
US